VELSIPITY

Arena Pharmaceuticals, Inc.

Application Filed: 2019-06-27
Trademark Application Details
Trademark Logo VELSIPITY

Mark For: VELSIPITY® trademark registration is intended to cover the categories of pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders. [all]

Status

2023-03-21 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88491734
Registration Number1585866
Mark Literal ElementsVELSIPITY
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-06-16
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameAllison Strickland Ricketts
Attorney Docket NumberARPI 1908455
Law Office AssignedN60
Employee NameBHUPATHI, TARA LUISE

Timeline

2019-06-27Application Filed
2019-09-23Location: TMO LAW OFFICE 124 - EXAMINING ATTORNEY ASSIGNED
2019-09-23Status: Live/Pending
2019-09-23Transaction Date
2020-04-21Published
2020-06-16Location: INTENT TO USE SECTION
2022-11-09Status: A fifth request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Arena Pharmaceuticals, Inc.
Address235 East 42nd Street New York, NEW YORK UNITED STATES 10017
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Drawing2019-06-27
TEAS RF New Application2019-06-27
Preliminary Amendment2019-08-01
Amendment and Mail Process Complete2019-08-14
XSearch Search Summary2019-09-19
Notation to File2019-09-23
Priority Action2019-09-23
Examiners Amendment2020-03-18
Notation to File2020-03-18
Amendment and Mail Process Complete2020-03-19
TRAM Snapshot of App at Pub for Oppostn2020-03-19
Notice of Publication2020-04-01
Notification Of Notice of Publication2020-04-01
OG Publication Confirmation2020-04-21
Notice of Allowance2020-06-16
Extension of Time to File SOU2020-12-14
ITU Extension Approval2020-12-16
ITU Unit Action2020-12-16
Extension of Time to File SOU2021-05-24
ITU Extension Approval2021-05-26
ITU Unit Action2021-05-26
Extension of Time to File SOU2021-11-23
ITU Extension Approval2021-11-25
ITU Unit Action2021-11-25
Change Address or Representation Form2022-01-25
Extension of Time to File SOU2022-06-02
ITU Extension Approval2022-06-04
ITU Unit Action2022-06-04
Change Address or Representation Form2022-09-16
Extension of Time to File SOU2022-10-31
ITU Extension Approval2022-11-10
ITU Unit Action2022-11-10

Attorney of Record

ALLISON STRICKLAND RICKETTS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
151 WEST 42ND STREET, 17TH FLOOR
NEW YORK, NY 10036

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for human use; Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, autoimmune diseases and dermatological diseases and disorders
GS0051Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-11-10
SOU EXTENSION 5 GRANTED2022-11-0976538
CASE ASSIGNED TO INTENT TO USE PARALEGAL2022-11-0776538
TEAS EXTENSION RECEIVED2022-10-31
SOU EXTENSION 5 FILED2022-10-3176538
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2022-09-16
TEAS CHANGE OF OWNER ADDRESS RECEIVED2022-09-16
TEAS CHANGE OF CORRESPONDENCE RECEIVED2022-09-16
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2022-09-16
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2022-09-1688888
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-06-04
TEAS EXTENSION RECEIVED2022-06-02
SOU EXTENSION 4 GRANTED2022-06-0298765
SOU EXTENSION 4 FILED2022-06-0298765
ASSIGNED TO EXAMINER2022-05-2791244
TEAS CHANGE OF OWNER ADDRESS RECEIVED2022-01-25
TEAS CHANGE OF CORRESPONDENCE RECEIVED2022-01-25
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2022-01-2588888
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-11-25
TEAS EXTENSION RECEIVED2021-11-23
SOU EXTENSION 3 GRANTED2021-11-2398765
SOU EXTENSION 3 FILED2021-11-2398765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-05-26
TEAS EXTENSION RECEIVED2021-05-24
SOU EXTENSION 2 GRANTED2021-05-2498765
SOU EXTENSION 2 FILED2021-05-2498765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-12-16
TEAS EXTENSION RECEIVED2020-12-14
SOU EXTENSION 1 GRANTED2020-12-1498765
SOU EXTENSION 1 FILED2020-12-1498765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-06-16
PUBLISHED FOR OPPOSITION2020-04-21
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-04-21
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-04-01
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2020-03-186328
EXAMINERS AMENDMENT E-MAILED2020-03-186328
EXAMINERS AMENDMENT -WRITTEN2020-03-1891234
EXAMINER'S AMENDMENT ENTERED2020-03-1888888
APPROVED FOR PUB - PRINCIPAL REGISTER2020-03-18
PRIORITY ACTION WRITTEN2019-09-2391234
PRIORITY ACTION E-MAILED2019-09-236326
NOTIFICATION OF PRIORITY ACTION E-MAILED2019-09-236326
ASSIGNED TO EXAMINER2019-09-1891234
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED2019-08-1370633
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED2019-08-1370633
ASSIGNED TO LIE2019-08-0870633
TEAS VOLUNTARY AMENDMENT RECEIVED2019-08-01
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-07-08
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2019-07-08
NEW APPLICATION ENTERED IN TRAM2019-07-01
NEW APPLICATION ENTERED2019-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed